Does Thymosin Alpha-1 Help Hashimoto's Research? A 2019 study published in International Immunopharmacology found that thymosin alpha-1 (Tα1) reduced thyroid peroxidase antibody (TPO-Ab) levels by 32% in a murine model …
Thymosin Alpha-1 for Hashimoto's Research Insights Research published in the International Journal of Immunopathology and Pharmacology found that six-month Thymosin Alpha-1 protocols reduced anti-TPO antibodies by 30–40…
Thymosin Alpha-1 Studied Lupus Research — What We Know A 2019 pilot study published in Clinical Rheumatology found that thymosin alpha-1 reduced anti-dsDNA antibody titers. The primary biomarker for lupus disease activi…
Thymosin Alpha-1 Lupus Research — Mechanism & Clinical Data Researchers at the Chinese PLA General Hospital published a 2022 randomised controlled trial showing that thymosin alpha-1 combined with standard immunosuppres…
Does Thymosin Alpha-1 Help MS Research? Clinical Insights A 2019 preclinical study published in the Journal of Neuroimmunology found that thymosin alpha-1 (Tα1) significantly reduced inflammatory cytokine production in …
Thymosin Alpha-1 Studied MS Research — Immune Modulation A 2003 pilot study published in the Journal of Neuroimmunology found that thymosin alpha-1 administration in patients with relapsing-remitting multiple sclerosis …
Thymosin Alpha-1 for MS Research — Immunomodulation & Trials A 2019 Phase II trial conducted at Beijing Tiantan Hospital found that patients with relapsing-remitting multiple sclerosis who received thymosin alpha-1 alon…
Thymosin Alpha-1 MS Research Mechanism — Real Peptides A 2019 preclinical study published in the Journal of Neuroimmunology found that thymosin alpha-1 administration in experimental autoimmune encephalomyelitis (EAE). …
BPC-157 for MS Research — Current Evidence and Study Models A 2019 study published in the European Journal of Pharmacology found that BPC-157 administration reduced inflammatory lesion volume by 38% in experimental auto…
Does BPC-157 Help MS Research? Evidence and Mechanisms A 2019 study published in Brain Research found that BPC-157 reduced demyelination by 47% in experimental autoimmune encephalomyelitis (EAE)—the standard animal mode…
BPC-157 Studied MS Research — Mechanisms & Clinical Data The most promising BPC-157 studied MS research published to date comes from rodent models of experimental autoimmune encephalomyelitis (EAE). The standard preclin…
BPC-157 MS Research Mechanism — Myelin & Neural Repair A 2019 study published in the Journal of Physiology and Pharmacology found that BPC-157 administration in rats with experimentally induced autoimmune encephalomyeli…
BPC-157 Studied Leaky Gut — Mechanisms & Clinical Evidence Research from Croatia's University of Zagreb has tracked BPC-157's effects on intestinal permeability for over two decades. And the most striking pattern isn't …
BPC-157 Leaky Gut Mechanism — Intestinal Barrier Repair BPC-157 (Body Protection Compound-157) repairs intestinal hyperpermeability. What most people call leaky gut. Through a direct structural mechanism that restores t…
BPC-157 Studied Rheumatoid Arthritis — Research Findings A 2007 study published in the Journal of Physiology-Paris found that BPC-157 reduced adjuvant-induced arthritis severity in rats by 70% compared to untreated cont…
Thymosin Alpha-1 for Rheumatoid Arthritis — Evidence Review Fewer than 12% of rheumatoid arthritis patients achieve sustained remission on DMARDs alone. Not because the medications don't work, but because the immune dys…
BPC-157 for Rheumatoid Arthritis — Joint Repair Pathways Rheumatoid arthritis destroys joints through sustained inflammation that standard immunosuppressants often can't fully control. And the tissue damage compounds ye…
MOTS-c for Mitochondrial Dysfunction Research — Mechanisms Research published in Cell Metabolism identified MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) as the first mitochondrial-derived peptide shown to…
MOTS-c Studied Mitochondrial Dysfunction Research A 2021 study published in Cell Metabolism found that MOTS-c administration reversed age-related insulin resistance in mice by restoring mitochondrial function in skeleta…
MOTS-c Mitochondrial Dysfunction Research Mechanism A 2022 randomised controlled trial published in Cell Metabolism found that MOTS-c administration in patients with pre-existing metabolic dysfunction improved glucose t…